Sort
15,842 grants matching “pancreatic cancer”
Discovery of Novel Inhibitors Targeting trans-Golgi Network Acidification in Pancreatic Cancer
$612,825Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
$612,272David G Denardo · Washington University · U01 · FY2024 · CA
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy
$612,076Konstantin V Sokolov · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
$611,615William C Hahn · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Neuro-immune regulation of intestinal inflammation
$611,475David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · DK
Optical imaging of pancreas cancer organoids for drug development and personalized treatment
$611,452Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2019 · CA
Centralization of Cancer Care: Implications for Access, Outcomes, and Disparities
$611,389Bruce L. Jacobs · University Of Pittsburgh At Pittsburgh · R37 · FY2023 · CA
Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation
$611,350Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2020 · CA
Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation
$611,350Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2021 · CA
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis
$611,085Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Animal Core Facility
$611,022John Curlee Wilkinson · North Dakota State University · P20 · FY2025 · GM
Generation of antibody-drug conjugates by proximity-based sortase-mediated ligation
$610,986Feifan Yu · Alphathera, Inc. · R44 · FY2022 · CA
Bottlebrush polymer prodrugs for targeted delivery of combination therapies and in vivo imaging of pharmacological response
$610,792Jeremiah Allen Johnson · Massachusetts Institute Of Technology · R01 · FY2023 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
$610,603Brad Kahl · University Of Wisconsin-Madison · U10 · FY2008 · CA
The use of chitosan for cancer vaccine delivery
$610,288John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The connection of innate and adaptive anti-cancer immunity
$610,288John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
THE AGING MICROENVIRONMENT AS A DRIVER OF PANCREATIC CANCER METASTASIS
$610,059The Johns Hopkins University · · FY2025 · Defense Health Agency
Molecular Profiling of Pancreatic Cancer
$609,814Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Phenotypic marker-guided development of selective antimetastasis therapeutic leads
$609,809Sui Huang · Northwestern University At Chicago · R01 · FY2024 · CA
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
$609,798Xiao-Ou Shu · Vanderbilt University Medical Center · R01 · FY2022 · CA
Detecting cancer early with targeted nano-probes for vascular signatures
$609,536Douglas Hanahan · University Of California, San Francisco · R01 · FY2008 · CA
Designing a Plan of Action for Better Access and Quality of Surgery for African-Americans with Gastrointestinal Cancers in the Deep South
$609,503Maria Pisu · University Of Alabama At Birmingham · R01 · FY2022 · MD
Biological Functions of Chromosomal Proteins
$609,495Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
$609,472Debabrata Mukhopadhyay · Mayo Clinic Rochester · R01 · FY2010 · CA
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer
$609,412Anna E Lokshin · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA